Effects of tranexamic acid on postoperative bleeding and related hematochemical variables in coronary surgery: Comparison between on-pump and off-pump techniques

Journal of Thoracic and Cardiovascular Surgery

Volumn 128, Issue 1, 2004, Pages 83-91

  Casati, Valter ^a   Della Valle, Patrizia ^b   Benussi, Stefano ^b   Franco, Annalisa ^b   Gerli, Chiara ^b   Baili, Paolo ^c   Alfieri, Ottavio ^b   D'Angelo, Armando ^b  

^a Division of Cardiovascular Anesthesia and Intensive Care   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

23; 25

Indexed keywords

ANTITHROMBIN III; D DIMER; FIBRINOGEN; HEMOGLOBIN; IMMUNOGLOBULIN G; INTERLEUKIN 6; PLASMINOGEN; TRANEXAMIC ACID; TRYPSIN INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OFF PUMP CORONARY SURGERY; PLASMA TRANSFUSION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

AGED; ANTIFIBRINOLYTIC AGENTS; BIOLOGICAL MARKERS; BLOOD COAGULATION; BLOOD COAGULATION TESTS; BLOOD LOSS, SURGICAL; CORONARY ARTERY BYPASS; CORONARY CIRCULATION; DOUBLE-BLIND METHOD; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYSIS; HUMANS; IMMUNOGLOBULIN G; INTERLEUKIN-6; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; STROKE VOLUME; TRANEXAMIC ACID; TREATMENT OUTCOME;

EID: 3042811398     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2003.10.034     Document Type: Article

References (26)

1. Woodman R.C., Harker L.A. Bleeding complications associated with cardiopulmonary bypass. Blood. 76:1990;1680-1697
2. Rinder C.S., Bohnert J., Rinder H.M., Mitchell J., Ault K., Hillmann R. Platelet activation and aggregation during cardiopulmonary bypass. Anesthesiology. 75:1991;388-393
3. Holloway D.S., Summariva L., Sandersara J., Vagher J.P., Alexander J.C., Caprini J.A. Decreased platelet number and function and increased fibrinolysis contribute to postoperative bleeding in cardiopulmonary bypass patients. Thromb Haemost. 59:1988;62-67
4. Kojima T., Gando S., Kemmotsu O., Mashio H., Goda Y., Kawahigashi H., et al. Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass role of tissue factor pathway inhibitor. J Cardiothorac Vasc Anesth. 15:2001;60-64
5. Laffey J.G., Boylan J.F., Cheng D.C. The systemic inflammatory response to cardiac surgery. Anesthesiology. 97:2002;215-252
6. Asimakopoulos G., Smith P.L., Ratnatunga C.P., Taylor K.M. Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass. Ann Thorac Surg. 68:1999;1107-1115
7. Yacoub M. Off-pump coronary bypass surgery. In search of an identity. Circulation. 104:2001;1743-1745
8. Cartier R., Brann S., Dagenais F., Martineau R., Couturier A. Systematic off-pump coronary artery revascularization in multivessel disease experience of three hundred cases. J Thorac Cardiovasc Surg. 119:2000;221-229
9. Varghese D., Yacoub M.H., Trimlett R., Amrani M. Outcome of non-elective coronary artery bypass grafting without cardio-pulmonary bypass. Eur J Cardiothorac Surg. 19:2001;245-248
10. Nader N.D., Khadra W.Z., Reich N.T., Bacon D.R., Salerno T.A., Panos A.L. Blood product use in cardiac revascularization comparison of on- and off-pump techniques. Ann Thorac Surg. 68:1999;1640-1643
11. Ascione R., Williams S., Lloyd C.T., Sundaramoorthi T., Pitsis A.A., Angelini G.D. Reduced postoperative blood loss and transfusion requirement after beating-heart coronary operations a prospective randomized study. J Thorac Cardiovasc Surg. 121:2001;689-696
12. van Dijk D., Nierich A.P., Jansen E.W., Nathoe H.M., Suyker J.L., Diephius J.C., et al. Early outcome after off-pump versus on-pump coronary bypass surgery. Results from a randomized study. Circulation. 104:2001;1761-1766
13. Levi M., Cromheecke M.E., de Jonge E., Prins M.H., de Mol B.J., Briet E., et al. Pharmacological strategies to decrease excessive blood loss in cardiac surgery a meta-analysis of clinically relevant endpoints. Lancet. 354:1999;1940-1947
14. Casati V., Guzzon D., Oppizzi M., Cossolini M., Torri G., Calori G., et al. Hemostatic effects of aprotinin, tranexamic acid and ε-aminocaproic acid in primary cardiac surgery. Ann Thorac Surg. 68:1999;2252-2257
15. Casati V., Guzzon D., Oppizzi M., Bellotti F., Franco A., Gerli C., et al. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations effects on perioperative bleeding and allogeneic transfusions. J Thorac Cardiovasc Surg. 120:2000;520-527
16. Casati V., Bellotti F., Gerli C., Franco A., Oppizzi M., Cossolini M., et al. Tranexamic acid administration after cardiac surgery. A prospective, randomized, double-blind, placebo controlled study. Anesthesiology. 94:2001;8-14
17. Casati V., Sandrelli L., Speziali G., Calori G., Grasso M.A., Spagnolo S. Hemostatic effects of tranexamic acid in elective thoracic aortic surgery a prospective, randomized, double-blind, placebo-controlled study. J Thorac Cardiovasc Surg. 123:2002;1084-1091
18. Casati V., Gerli C., Franco A., Torri G., D'Angelo A., Benussi S., et al. Tranexamic acid in off-pump coronary surgery a preliminary, randomized, double-blind, placebo-controlled study. Ann Thorac Surg. 72:2001;470-475
19. Casati V., Gerli C., Franco A., Della Valle P., Benussi S., Alfieri O., et al. Activation of coagulation and fibrinolysis during coronary surgery. On-pump versus off-pump techniques. Anesthesiology. 95:2001;1103-1109
20. Higgins T.L., Estafanous F.G., Loop F.D., Beck G.J., Blum J.M., Paranandi L., et al. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients. A clinical severity score. JAMA. 267:1992;2344-2348
21. Burman J.F., Chung H.I., Lane D.A., Philippou H., Adami A., Lincoln J.C. Role of factor XII in thrombin generation and fibrinolysis during cardiopulmonary bypass. Lancet. 344:1994;1192-1193
22. Verstraete M. Clinical application of inhibitors of fibrinolysis. Drugs. 29:1985;236-261
23. Sherry S., Marder V.J. Therapy with antifibrinolytic agents. Colman R.W., Hirsh J., Marder V.J., Salzamn E.W. Hemostasis and thrombosis, basic principles and clinical practice. 1994;335-352 JB Lippincott, Philadelphia
24. Horrow J.C., Hlavacek J., Strong M.D., Collier W., Brodsky I., Goldman S.M., et al. Prophylactic tranexamic acid decreases bleeding after cardiac operations. J Thorac Cardiovasc Surg. 99:1990;70-74
25. Blauhut B., Harringer W., Bettelheim P., Doran J.E., Spath P., Lundsgarard-Hansen P. Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 108:1994;1083-1091
26. Greilich P.E., Okada K., Latham P., Kumar R.R., Jessen M.E. Aprotinin but not ε-aminocaproic acid decreases interleukin-10 after cardiac surgery with extracorporeal circulation randomized, double-blind, placebo-controlled study in patients receiving aprotinin and ε-aminocaproic acid. Circulation. 104:(Suppl 1):2001;I265-269